ArticleJournal of the American Pharmacists Association : JAPhA
Pharmacist prescriptive authority for smoking cessation medications in the United States.
Article in Journal of the American Pharmacists Association : JAPhA. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Effectiveness of Hospital Pharmacist Interventions for COPD Patients: A Systematic Literature Review and Logic Model.International journal of chronic obstructive pulmonary disease · 2022Pooled it
- Assessment of an intensive education program for pharmacists on treatment of tobacco use disorder using an objective structured clinical examination: a randomized controlled trial.BMC medical education · 2022Trial
- Outcomes of a randomized trial evaluating two approaches for promoting pharmacy-based referrals to the tobacco quitline.Journal of the American Pharmacists Association : JAPhATrial
- Jamaican Community Pharmacists-Determined Barriers to Availability of Smoking Cessation Aids.Pharmacy (Basel, Switzerland) · 2025Article
- Tobacco Treatment Disparities Among California Medicaid Members With and Without Chronic Disease Who Smoke.AJPM focus · 2025Article
- Patient awareness, perceptions, and attitudes towards pharmacists prescribing tobacco cessation medications.Research in social & administrative pharmacy : RSAP · 2023Article
- Tobacco Education in Doctor of Pharmacy Programs in the United States (2021-2022).American journal of pharmaceutical education · 2023Article
- Federal pharmacist Paxlovid prescribing authority: A model policy or impediment to optimal care?Exploratory research in clinical and social pharmacy · 2023Article
- Prescription Smoking-Cessation Medication Fills and Spending, 2009-2019.American journal of preventive medicine · 2022Article
- Implementing Brief Tobacco Cessation Interventions in Community Pharmacies: An Application of Rogers' Diffusion of Innovations Theory.Pharmacy (Basel, Switzerland) · 2022Article
- Cigarette Promotions in U.S. Pharmacies.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022Article
- Use of research evidence varied in efforts to expand specific pharmacist autonomous prescriptive authority: an evaluation and recommendations to increase research utilization.Health research policy and systems · 2022Article
- Pharmacist Prescriptive Authority: Lessons from Idaho.Pharmacy (Basel, Switzerland) · 2020Article
- Provision of free nicotine replacement therapy to parental smokers in the pediatric emergency setting.Tobacco prevention & cessation · 2020Article
- The Report of the 2018-2019 Professional Affairs Standing Committee: The Role of Educators in Pharmacy Practice Transformation.American journal of pharmaceutical education · 2019Article
- Pharmacists' Patient Care Process: A State "Scope of Practice" Perspective.Innovations in pharmacy · 2019Article
- An Innovative Approach to Improving the Proposed CMS Star Rating "Statin Use in Persons with Diabetes".Journal of managed care & specialty pharmacy · 2018Article
- Pharmacy-Based Travel Health Services: State Approaches to Prescriptive Authority.The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians · 2018Article
- Primary healthcare policy and vision for community pharmacy and pharmacists in the United States.Pharmacy practiceArticle
- Patient perceptions of pharmacist-provided tobacco treatment at a federally qualified health center.Journal of the American Pharmacists Association : JAPhAArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
objectivesTo characterize the status of state laws regarding the expansion of pharmacists' prescriptive authority for smoking cessation medications and to summarize frequently asked questions and answers that arose during the associated legislative debates. DATA SOURCES: Legislative language was reviewed and summarized for all states with expanded authority, and literature supporting the pharmacist's capacity for an expanded role in smoking cessation is described. SUMMARY: The core elements of autonomous tobacco cessation prescribing models for pharmacists vary across states. Of 7 states that currently have fully or partially delineated protocols, 4 states (Colorado, Idaho, Indiana, New Mexico) include all medications approved by the U.S. Food and Drug Administration for smoking cessation, and 3 (Arizona, California, Maine) include nicotine replacement therapy products only. The state protocol in Oregon is under development. Most states specify minimum cessation education requirements and define specific elements (e.g., patient screening, cessation intervention components, and documentation requirements) for the autonomous prescribing models.
conclusionThrough expanded authority and national efforts to advance the tobacco cessation knowledge and skills of pharmacy students and licensed pharmacists, the profession's role in tobacco cessation has evolved substantially in recent years. Eight states have created, or are in the process of creating, pathways for autonomous pharmacist prescriptive authority. States aiming to advance tobacco control strategies to help patients quit smoking might consider approaches like those undertaken in 8 states.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.